Skip to main content

Table 1 The characteristics of study samples

From: Prevalence of CCR5delta32 in Northeastern Iran

 Wild typeMutantbHeterozygoteTotal
Sexa46.1 (m), 53.9 (f)100.0 (f)45.5 (m), 54.5 (f)45.9 (m), 54.1 (f)
Age (yr)46.09 ± 7.2537.0046.45 ± 8.1246.1 ± 7.27
Weight (Kg)71.92 ± 13.2761.277.11 ± 11.872.04 ± 13.2
Height (m)1.62 ± .091.511.64 ± .101.62 ± .1
BMI27.5 ± 4.7926.8429.21 ± 6.2927.5 ± 4.8
Inflammatory marker
 Hs-CRP1.64 (3.11–1.00)0.751.45 (3.40–0.87)1.62 (3.10–1.00)
Smoking
 Non-smokera63.5100.081.864.1
 Ex-smokera10.00.018.29.7
 Current smokera26.50.00.026.2
Diabetes
 Diabetic conditiona15.40.020.015.5
Biochemical parameters
 Glucose (mg/dL)82.0 (92.0–74.5)71.0082.0 (96.0–74.0)82.0 (92.0–74.5)
 Cholesterol (mg/dL)187.00 (214.00–163.00)175.00182.00 (233.00–153.00)187.00 (214.00–163.00
 HDL (mg/dL)41.5 ± 9.039.3041.43 ± 10.8241.5 ± 9.0
 Triglyceride (mg/dL)116.0 (172.0–81.50)74.0092.00 (210.00–74.00)115.0 (172.0–81.50)
 LDL (mg/dL)118.88 (141.6–95.75)102.06121.88 (160.80–84.00)118.92 (141.6–95.75)
  1. The results showed as mean ± SD and median (IQ3-IQ1) for normal and abnormal distribution data, respectively. a The numbers represent percentage of prevalence; b mutant group have only one subject